Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study
Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Left Ventricular Assist Devices for Lifelong Support
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study
Is Acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF
Primary Prevention of Heart Failure in Women

|<< 1 2 3 4 5 6 7 ...>>|

Clinical Trial

November 10, 2018

JOURNAL：N Engl J Med.

Article Link

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

SD Wiviott，I Raz，DECLARE–TIMI 58 Investigators.

15512

Keywords: Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Acute Heart Failure, Hypertension, Smoking

FULL TEXT PDF